MarketPulse

market share loss

11 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Nvidia's China Collapse: $0 Revenue Looms, But AI Boom May Cushion Blow

Nvidia's China market share collapsed to zero due to U.S. export restrictions, but strong AI demand from U.S. hyperscalers is projected to drive Q1 FY2027 revenue to $78 billion, up 77% year-over-year.
NVDAMSFTBABABIDUAI chipsmarket share loss
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

LKQ Stock Plunged on Hidden FinishMaster Woes, Shareholders Sue for Fraud

LKQ faces securities fraud lawsuit over FinishMaster acquisition integration failures. Stock declined significantly after undisclosed customer losses and guidance cuts.
LKQsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Daniel Miller

Ford's EV Collapse: From No. 2 to Also-Ran in Critical Market

Ford's Q1 2026 EV sales collapsed 70% year-over-year to 6,860 units, losing its No. 2 market ranking to Toyota and competitors, forcing a pivot toward affordable vehicles and a 2027 pickup launch.
TMTSLAFFpBFpC+2electric vehiclesmarket share loss
Investing.comInvesting.com··Thomas Hughes

Nike Stock Crashes 75% From Peak as Turnaround Stalls, Guidance Disappoints

Nike stock has collapsed 75% from peak as turnaround stalls. Q4 guidance projects 3% revenue decline versus 2% analyst growth expectations, amid intensifying competition and margin pressure.
ONONNKEearnings missrevenue decline
The Motley FoolThe Motley Fool··Trevor Jennewine

Wall Street Flags 32-43% Downside Risk in Micron and Intel Despite Chip Rally

Analysts warn investors to sell Micron and Intel, citing temporary supply tailwinds for Micron and persistent challenges at Intel threatening valuations.
NVDAAMDMUTSMINTCsemiconductor stocksAI infrastructure
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Boston Scientific Faces Class Action Over $BSC Stock Plunge, Missed Earnings

Boston Scientific faces class action lawsuit after 17% stock decline following $0.45 EPS miss versus $0.48-$0.52 guidance, amid alleged undisclosed Electrophysiology market share losses.
BSXclass action lawsuitstock decline
The Motley FoolThe Motley Fool··Jeremy Bowman

The Trade Desk's Customer Exodus Signals Deeper Trouble for Adtech Giant

The Trade Desk faces major customer defections from Dentsu, WPP, and Publicis over fees and transparency, threatening growth and 12-year retention streak.
METAAMZNGOOGGOOGLAAPL+4market share lossgrowth deceleration
Investing.comInvesting.com··Itai Smidt

Novo Nordisk Reassesses Growth Outlook Following CagriSema Trial Setback

Novo Nordisk stock drops 15.9% after CagriSema obesity drug fails trial versus competitor tirzepatide, signaling intensifying competition in the GLP-1 market despite Wegovy's strength.
LLYNVOGLP-1 drugsWegovy
Investing.comInvesting.com··Dan Schmidt

Three Stocks Signal Deeper Trouble Ahead as Earnings Deteriorate

Three major stocks—PayPal, Genuine Parts, and Vulcan Materials—show deteriorating earnings and bearish technical signals, signaling deeper economic weakness ahead.
PYPLGPCVMCstock declineearnings miss
The Motley FoolThe Motley Fool··Jennifer Saibil

Fiserv Targets Recovery: AI Strategy and Execution Risk Define Outlook

Fiserv pursues AI-driven turnaround after 74% stock decline from earnings misses. Q4 stabilization signals renewed execution discipline; next three quarters critical for recovery.
NOWPYPLFISVearnings missguidance
The Motley FoolThe Motley Fool··Dan Caplinger

Intel Reports $300M GAAP Loss Despite Stock Recovery and Margin Improvements

Intel posted $300M loss in 2025 despite 50% stock gain and margin improvements. New CEO pursues CPU-focused AI strategy to regain market share.
NVDAAMDINTCsemiconductor industryCEO transition